Skip to content

Drug interactions

Azelastine-fluticasone + Mavacamten

Severity: Minor

Azelastine-fluticasone and Mavacamten: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Azelastine may weakly inhibit CYP2C19 and could raise mavacamten exposure. Higher mavacamten levels can lower left ventricular ejection fraction and cause heart failure, but the effect of a nasal spray is probably small.

What this interaction means in plain words

Azelastine-fluticasone and Mavacamten have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Azelastine-fluticasone belongs to Respiratory; Mavacamten belongs to Cardiovascular.

Evidence level: Low

Why it happens

Possible weak CYP2C19 inhibition reduces mavacamten metabolism.

What to do

Continue routine echocardiographic monitoring of left ventricular ejection fraction. Reassess mavacamten dosing if function declines after azelastine is started.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Azelastine-fluticasone and Mavacamten, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Azelastine-fluticasone with Mavacamten?

MediHelp rates the interaction as minor. Azelastine-fluticasone and Mavacamten have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Azelastine may weakly inhibit CYP2C19 and could raise mavacamten exposure. Higher mavacamten levels can lower left ventricular ejection fraction and cause heart failure, but the effect of a nasal spray is probably small.

How serious is the interaction between Azelastine-fluticasone and Mavacamten?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Continue routine echocardiographic monitoring of left ventricular ejection fraction. Reassess mavacamten dosing if function declines after azelastine is started.

What other medicines interact with Azelastine-fluticasone?

MediHelp also lists interactions of Azelastine-fluticasone with, for example, Calcium / magnesium / potassium / sodium oxybates, Sodium oxybate, Alfentanil. The full list is on the Azelastine-fluticasone page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in